Gene: USP17L23
Official Full Name: ubiquitin specific peptidase 17 like family member 23provided by HGNC
Gene Summary: Predicted to enable cysteine-type deubiquitinase activity. Predicted to be involved in protein deubiquitination. Predicted to be located in endoplasmic reticulum and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12757 | USP17L23 Knockout cell line (HeLa) | Human | USP17L23 | 1:3~1:6 | Negative | Online Inquiry |
KO12758 | USP17L23 Knockout cell line (HCT 116) | Human | USP17L23 | 1:2~1:4 | Negative | Online Inquiry |
KO12759 | USP17L23 Knockout cell line (A549) | Human | USP17L23 | 1:3~1:4 | Negative | Online Inquiry |
USP17L23 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to help researchers investigate the biological functions and pathways regulated by the USP17L23 gene. This gene encodes a protein that is involved in various cellular processes, including ubiquitination and protein degradation, which are crucial for maintaining cellular homeostasis and regulating responses to stress. By knocking out the USP17L23 gene, these cell lines allow researchers to study the downstream effects on cellular behavior and signaling pathways, providing insights into gene function and potential disease mechanisms.
The primary function of the USP17L23 Gene Knockout Cell Lines lies in their ability to mimic physiological conditions devoid of USP17L23-related signaling. This is achieved through the CRISPR-Cas9 gene-editing technology, resulting in precise gene deletions. Upon analyzing these knockout cells, researchers can uncover important cellular mechanisms related to apoptosis, cell cycle regulation, and response to external stimuli, making this product invaluable for both basic and applied biological research.
Scientifically, these knockout cell lines serve as pivotal tools in understanding the role of USP17L23 in various diseases, including cancers and inflammatory disorders. Their applications extend into the development of therapeutic strategies and the discovery of novel drug targets, enhancing the translational impact of preclinical studies.
Compared to alternative gene knockout approaches, USP17L23 Gene Knockout Cell Lines offer robust performance, high specificity, and reproducibility, ensuring that researchers obtain reliable data. The ease of use and adaptability of these cell lines for various assays further adds to their appeal, making them indispensable assets in both academic and industrial laboratories.
For researchers and clinicians striving to elucidate the complexities of gene functions and contribute to advancements in medical science, the USP17L23 Gene Knockout Cell Lines are an essential component of their toolkit. Our commitment to excellence in biogenetic resources, backed by years of expertise in genetic engineering and cell biology, ensures that you are equipped with high-quality products designed for impactful research and clinical outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.